New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. [electronic resource]
- Current drug targets Jun 2001
- 213-4 p. digital
Publication Type: Comment; Letter
1389-4501
Adenosine Triphosphatases--therapeutic use Antigens, CD--therapeutic use Apyrase--therapeutic use Blood Platelets--drug effects Humans Lipid Metabolism Platelet Aggregation Inhibitors--therapeutic use Thrombosis--drug therapy